Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Driving Efficiency in Farm Loan Delivery. Document Number: 2026-18164
Buy this Course
FR-26-2192-1
FDA’s Classification of Plazomicin Test System: Ensuring Safety and Innovation
$9.99
Discover how the FDA’s classification of the plazomicin test system into class II (special controls) ensures safety and effectiveness while enhancing patient access to innovative medical technologies. This course details the specific requirements and benefits of the classification, providing crucial insights for professionals navigating the regulatory landscape.
In this course you will learn the following:
* Understand the classification process and criteria for the plazomicin test system.
* Identify the special controls required for compliance with the new classification.
* Recognize the benefits of the De Novo classification process in reducing regulatory burdens.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.
Why This Course is Important
Professionals who skip this course might miss out on critical insights into how the FDA’s classification impacts device safety, regulatory compliance, and patient access to innovative therapies.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Plazomicin Test System.
Key regulatory references include:
Course SKU
FR-25-1358-1